LONDON & KYOTO, Japan--(BUSINESS WIRE)--The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, has signed a patent licence agreement with iPS Academia Japan, which represents a pivotal step in the development of the UK's GMP induced pluripotent stem (iPS) cell bank.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
